Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitis.
Multiple sclerosis in New Zealand.
Aquaporin-4 autoimmunity.
Magnetic resonance monitoring of lesion evolution in multiple sclerosis.
Different MOG35-55 concentrations induce distinguishable inflammation through early regulatory response by IL-10 and TGF-β in mice CNS despite unchanged clinical course.
Sphingosine-1 phosphate and central nervous system.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
Botulinum Toxin-What Urologic Uses Does the Data Support?
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Does robot-assisted gait training ameliorate gait abnormalities in multiple sclerosis? A pilot randomized-control trial.
Ambulation in adults with central neurologic disorders.
Microparticles: A New Perspective in Central Nervous System Disorders.
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
Neuroinflammation: Transport disruption in multiple sclerosis.
Lead Candidate (MIS416) Overview
A changing treatment landscape for multiple sclerosis: challenges and opportunities.
Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.
Iron and multiple sclerosis.

Pages